Overview

A Study to Evaluate Platlet Aggregation of Clopidogrel, EC Aspirin 81 mg, EC Omeprazole 40 mg Compare to PA32540

Status:
Completed
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
This study is designed to provide data on platelet aggregation of PA32540 plus clopidogrel dosed separately compared to EC aspirin 81 mg plus EC omeprazole 40 mg plus clopidogrel dosed concomitantly.
Phase:
Phase 1
Details
Lead Sponsor:
POZEN
Treatments:
Aspirin
Clopidogrel
Omeprazole
Ticlopidine